These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 22652310)

  • 1. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
    Guzzetta NA; Russell IA; Williams GD
    Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic and hemostatic stewardship: evaluation of clinical outcomes and adverse events of recombinant factor VIIa (Novoseven
    Marsh K; Green D; Raco V; Papadopoulos J; Ahuja T
    Ther Adv Cardiovasc Dis; 2020; 14():1753944720924255. PubMed ID: 32449469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
    Brenner B; Wiis J
    Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).
    Hacquard M; Durand M; Lecompte T; Boini S; Briançon S; Carteaux JP
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1320-7. PubMed ID: 21550261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?
    Okonta KE; Edwin F; Falase B
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):690-4. PubMed ID: 22811512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
    Tomita E; Takase H; Tajima K; Suematsu Y
    Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
    Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN
    Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Off-label use of recombinant factor VII (rFVIIa) in teaching hospitals in Paris in 2010].
    Bardon J; Fink J; de Montblanc J; Bergmann JF; Sarrut B; Benhamou D
    Ann Fr Anesth Reanim; 2013 Oct; 32(10):659-64. PubMed ID: 23953834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register.
    Isbister J; Phillips L; Dunkley S; Jankelowitz G; McNeil J; Cameron P
    Intern Med J; 2008 Mar; 38(3):156-65. PubMed ID: 17916172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.
    Tatoulis J; Theodore S; Meswani M; Wynne R; Hon-Yap C; Powar N
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose recombinant factor VIIa for massive bleeding: a single centre observational cohort study with 73 patients.
    Schmid P; Mordasini A; Luginbühl M; Regli B; Kohler HP; Zimmermann H; Inderbitzin D; Hirt A; Lämmle B; Alberio L
    Swiss Med Wkly; 2011; 141():w13213. PubMed ID: 21735365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of recombinant activated factor VII in randomized clinical trials.
    Levi M; Levy JH; Andersen HF; Truloff D
    N Engl J Med; 2010 Nov; 363(19):1791-800. PubMed ID: 21047223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy.
    Ekert H; Brizard C; Eyers R; Cochrane A; Henning R
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):389-95. PubMed ID: 16788315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence or no alternative? Taking responsibility for off-label prescribing.
    Ghinea N; Lipworth W; Kerridge I; Day R
    Intern Med J; 2012 Mar; 42(3):247-51. PubMed ID: 22432984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant activated factor VII in cardiac surgery: single-center experience.
    Singh SP; Chauhan S; Choudhury M; Malik V; Choudhary SK
    Asian Cardiovasc Thorac Ann; 2014 Feb; 22(2):148-54. PubMed ID: 24585784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.
    Downey L; Brown ML; Faraoni D; Zurakowski D; DiNardo JA
    Anesth Analg; 2017 May; 124(5):1431-1436. PubMed ID: 28319507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of recombinant factor VIIa in on-pump cardiac surgery: proceedings of the Canadian Consensus Conference.
    Karkouti K; Beattie WS; Crowther MA; Callum JL; Chun R; Fremes SE; Lemieux J; McAlister VC; Muirhead BD; Murkin JM; Nathan HJ; Wong BI; Yau TM; Yeo EL; Hall RI
    Can J Anaesth; 2007 Jul; 54(7):573-82. PubMed ID: 17602044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.